Drug trial outsourcing to foreign countries is rapidly becoming an attractive alternative for pharmaceutical companies. Carl Elliott, Medical School and Center for Bioethics, talks about how the danger is that we have no idea what's going on in these clinical trials.
Recently in Center for Bioethics Category
Financial conflicts-of-interest has been a growing issue in medicine. Leigh Turner, College of Pharmacy and Center for Bioethics, explains that bioethicists have to write about ethical issues related to medicine, health care, and biotechnology for the good of the industry.
Read on MinnPost
Prominent bioethicist Glenn McGee will soon be taking a job with a for-profit stem-cell company. Leigh Turner, College of Pharmacy and Center for Bioethics, wrote about the potential conflict of interest Dr. McGee got himself into.
Read on Inside Higher Ed
People enrolled in early stage trials for possible cancer treatments may underestimate the risks involved and overestimate the potential benefits. Mary Faith Marshall, Medical School and Center for Bioethics, discusses ways to improve the informed consent process.
A new survey shows one in ten doctors say in the last year they'd told a patient something that wasn't true. Steven Miles, Center for Bioethics, Medical School and University of Minnesota Physicians, explains that doctors have a duty to disclose the truth to patients.
Watch on FOX 9